Rashmi Arasappa, MD, is affiliated with the Department of Psychiatry at the National Institute of Mental Health and Neurosciences in Bangalore, India. The author has published research between 2009 and 2022 focusing on schizophrenia, schizoaffective disorders, and neurology. Topics studied include diagnostic challenges in neuropsychiatry, clinical presentations of persistent delusional disorder, and the effects of adjuvant treatments such as metformin and phytoestrogens in psychotic disorders. Collaborators frequently include Bangalore N. Gangadhar, Ganesan Venkatasubramanian, and others.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
